Decondensing cancer immunotherapy

A checkpoint inhibitor may switch off T cells in a surprising way

Authors

Institutions

Publication Details

Journal
Science
Published
2026-09-10
DOI
https://doi.org/10.1126/science.ael3828
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Decondensing cancer immunotherapy

Arup K. Chakraborty
Science
Cancer Immunotherapy and Biomarkers
article

Decondensing cancer immunotherapy

Arup K. Chakraborty
article en

Abstract

No abstract available for this paper.

ScienceVol. 393(6816)
Ragon Institute of MGH, MIT and Harvard (US), Massachusetts Institute of Technology (US)
Good health and well-being
Openalex Percentile: Top 13%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Decondensing cancer immunotherapy — Arup K. Chakraborty · Science (2026) | TGRS Research Map | TGRS